A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps

Mayo Clinic proceedings

Volumn 89, Issue 9, 2014, Pages 1257-1278

  Wright, R Scott ^a  

^a MAYO CLINIC   (United States)

^b Eau Claire Center   (United States)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ADVISORY COMMITTEE; AGE; AGED; ATHEROSCLEROSIS; BLOOD; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRACTICE GUIDELINE; RISK FACTOR;

ADULT; ADVISORY COMMITTEES; AGE FACTORS; AGED; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 85027923972     PISSN: None     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.06.016     Document Type: Review

References (0)